United to accelerate Cell and Gene Based Therapies
What we do
London Advanced Therapies (LAT) brings together the London scientific community working in the field of cell and gene-based therapies. Funded by Research England, and led by King’s College London, Imperial College London and University College London, LAT aims to catalyse London’s capabilities and outputs in the area of Advanced Therapies, through fostering collaborative work, facilitating commercial partnerships and creating a microclimate for innovation.
We aim at positioning London, and the UK, as a global leader in Advanced Therapies commercialisation, with sustainability embedded through the breadth of commercial partnerships.